Mundipharma International Ltd., of Cambridge, U.K., and Helsinn Group, of Lugano, Switzerland, signed a licensing and distribution agreement for antiemetic agent Aloxi (palonosetron hydrochloride) in Vietnam, extending an international collaboration. A 5-HT3 receptor antagonist, the compound has been approved in Vietnam. Terms were not disclosed.